ஜெநெடிக்ஸ் ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜெநெடிக்ஸ் ஆராய்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜெநெடிக்ஸ் ஆராய்ச்சி Today - Breaking & Trending Today

New DNA testing scheme against inherited disease in Rottweilers


Dogs Monthly
Aiming to combat Leukoencephalomyelopathy (LEMP), an inherited disease in the Rottweiler, The Kennel Club has approved a new official DNA test reporting scheme.
LEMP is a neurological disorder that affects the white matter of the central nervous system. The condition usually appears when dogs are around one to four years old; signs of LEMP include “slowly worsening problems walking, not walking in a straight line, spontaneous knuckling and dragging of the paws”. Dogs may become “increasingly immobile over a few months and their quality of life can quickly decrease”.
For the dog’s health to be affected, they must inherit two copies of an abnormal gene, one from the mother and one from the father. In some cases, a Rottweiler may have two copies of the mutation, but may never develop the condition. ....

Joanna Ilska , Health Test Results Finder , Kennel Club , Genetics Research , Research Manager , Breed Records Supplement , ஆரோக்கியம் சோதனை முடிவுகள் கண்டுபிடிப்பாளர் , கெநெல் சங்கம் , ஜெநெடிக்ஸ் ஆராய்ச்சி , ஆராய்ச்சி மேலாளர் ,

Global DNA Data Storage Markets and Technologies Report 2021: Review the DNA Data Storage Technologies, Patents, Including DNA Read and Write Technologies


Share this article
Share this article
ResearchAndMarkets.com s offering.
The global market for DNA data storage should grow from $36.4 million in 2020 to $525.3 million by 2025 with a compound annual growth rate (CAGR) of 70.6% for the period of 2020-2025.
The scope of the report includes DNA data storage technologies, applications, industries, initiatives, patents and companies. The markets for DNA data storage products and services are given for the years 2019, 2020 and 2025 (forecast).
This report reviews the DNA data storage technologies, including DNA read and write technologies. It then discusses significant large-scale research initiatives that impact DNA storage, read and write applications. The main market driving forces for DNA data storage products and services are discussed. ....

United States , Cegat Gmb , Pacific Biosciences , Kilobaser Gmbh , Laura Wood , Genemed Synthesis Inc , Innovation Ltd , National Microbiome Initiative , Iridia Inc , Brooks Life Sciences , Bioneer Corp , Molecular Assemblies Inc , Genetics Research , Quantapore Inc , California Inc , American Gut Consortium , Precision Medicine Initiative , Sigma Aldrich Corp , Bio Basic Inc , Genapsys Inc , Company Comparisons , Blue Heron Biotech , Synbio Technologies Inc , Office Hours Call , Biost Inc , Nuclera Nucleics Ltd ,

GenSight Biologics Announces Publication of Results from LUMEVOQ® Phase I/IIa Clinical Trial REVEAL in BioDrugs


Press release content from Business Wire. The AP news staff was not involved in its creation.
GenSight Biologics Announces Publication of Results from LUMEVOQ® Phase I/IIa Clinical Trial REVEAL in BioDrugs
February 15, 2021 GMT
Regulatory News:
GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced that the journal
BioDrugs has published results from REVEAL, the Phase I/IIa clinical trial that evaluated the safety of LUMEVOQ ® gene therapy in subjects with
ND4 Leber Hereditary Optic Neuropathy (LHON) and determined the dose subsequently used in the Phase III trials RESCUE and REVERSE. ....

United States , France General , United Kingdom , Lise Plaine , Magali Taiel , Catherine Vignal , James Palmer , Catherine Vignal Clermont , Marion Janic , Guillaume Van Renterghem , Fondation Ophtalmologique , Gensight Biologics , Denis Oshaughnessy , Thomas Gidoin , Centre Hospitalier National , University Of Pittsburgh Medical Center , University Of Pittsburgh School Medicine , Drug Administration , Rothschild Foundation Hospital , Department Of Neuro Ophthalmology , European Union , European Medicines Agency , Department Of Ophthalmology , Sight Biologics , Hereditary Optic Neuropathy , Leber Hereditary Optic Neuropathy ,